I covered Beam Therapeutics (BEAM) in April last year, when the stock had a market cap of $3.7bn. Today, despite some derisking events, it has a market cap of $2.6bn. The stock price has fallen 30% as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback